The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.10 - M&G Letter of Intent

1 Nov 2022 10:33

RNS Number : 9084E
Science Group PLC
01 November 2022
 

1 November 2022

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

Disclosure under Rule 2.10(a) of the Code in respect of the

RECOMMENDED CASH ACQUISITION

of

TP Group plc("TP Group" or the "Company")

by

Science Group plc("Science Group")

to be effected by way of scheme of arrangementunder Part 26 of the Companies Act 2006

 

On 31 October 2022 the independent boards of Science Group and TP Group announced that they had reached agreement on the terms of a recommended cash acquisition pursuant to which Science Group shall acquire the entire issued and to be issued ordinary share capital of TP Group (not already owned by Science Group). The Acquisition is to be effected by means of a Court‑sanctioned scheme of arrangement under Part 26 of the Companies Act.

 

Science Group has received an additional letter of intent from M&G Investment Management Limited to vote in favour of the Scheme at the Court Meeting and the resolutions to be proposed at the General Meeting, in respect of a total of 146,309,150 Shares, representing approximately 18.78 per cent. of the ordinary share capital of TP Group in issue on 31 October 2022 (being the latest practicable date prior to this announcement).

 

When taken with the existing letter of intent and irrevocable undertakings already procured by Science Group, details of which were announced on 31 October 2022, this brings the total number of shares subject to letters of intent and irrevocable undertakings to 240,742,997 Shares, representing approximately 30.90 per cent. of the ordinary share capital of TP Group in issued on 31 October 2022 (being the latest practicable date prior to this announcement).

 

Unless otherwise defined in this announcement, capitalised words and phrases used in this announcement shall have the same meanings given to them in the Scheme Document.

Enquiries:

Science Group plc

Sarah Cole, Group Legal Counsel & Company Secretary

Jon Brett, Group Finance Director

Tel: +44 (0) 1223 875 200

Stifel Nicolaus Europe Limited, exclusive financial adviser, nominated adviser and joint broker to Science Group

Nick Adams, Alex Price, Richard Short

Tel: +44 (0) 207710 7600

Liberum Capital Limited, Joint Broker to Science Group

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

 

The person responsible for this announcement on behalf of Science Group is Sarah Cole, Group Legal Counsel and Company Secretary.

IMPORTANT NOTICES

Stifel Nicolaus Europe Limited ("Stifel"), which is authorised and regulated in the UK by the FCA, is acting as Financial Adviser exclusively to Science Group and no one else in connection with the matters set out in this announcement. In connection with such matters, Stifel will not regard any other person as their client, nor will they be responsible to any other person for providing the protections afforded to clients of Stifel or for providing advice in relation to the contents of this announcement or any other matter referred to herein.

Liberum Capital Limited ("Liberum"), which is authorised and regulated in the UK by the FCA, is acting as Joint Broker exclusively for Science Group and no one else in connection with the matters set out in this announcement. In connection with such matters, Liberum will not regard any other person as their client, nor will they be responsible to any other person for providing the protections afforded to clients of Liberum or for providing advice in relation to the contents of this announcement or any other matter referred to herein.

Further information

This announcement is for information purposes only and is not intended to, and does not constitute, or form part of any offer, invitation, inducement or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of or exercise rights in respect of any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise. The Acquisition will be made solely through the Scheme Document and the accompanying Forms of Proxy (or by any other document by which the Acquisition is made), which will together contain the full terms and conditions of the Acquisition, including details of how to vote in respect of the Acquisition. Any decision in respect of, or other response to, the Acquisition should be made only on the basis of the information contained in the Scheme Document or any document by which the Acquisition is made.

This announcement has been prepared for the purpose of complying with the laws of England and Wales and the Takeover Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside England and Wales.

This announcement is not an advertisement and does not constitute a prospectus or prospectus equivalent document.

Availability on website

In accordance with Rule 26.1 of the Code, a copy of this announcement will be made available (subject to certain restrictions relating to persons resident in Restricted Jurisdictions), free of charge, on Science Group's website at http://www.sciencegroup.com by no later than 12:00 noon on the Business Day following the date of this announcement. Neither the contents of such website nor the content of any other website accessible from hyperlinks on such website is incorporated into, or forms part of, this Announcement.

If you are in any doubt about the contents of this announcement or the action you should take, you are recommended to seek your own independent financial advice immediately from your stockbroker, bank manager, solicitor, accountant or independent financial adviser duly authorised under the Financial Services and Markets Act 2000 (as amended) if you are resident in the United Kingdom or, if not, from another appropriately authorised independent financial adviser.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAEFFEANAFFA
Date   Source Headline
27th Jan 20237:00 amRNSCancellation - TP Group Plc
26th Jan 202310:16 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
26th Jan 202310:05 amRNSScheme Effective
26th Jan 20237:30 amRNSSuspension - TP Group Plc
25th Jan 20239:20 amRNSForm 8.5 (EPT/NON-RI)
24th Jan 20232:21 pmRNSCourt Sanction of Scheme of Arrangement
24th Jan 20238:55 amRNSForm 8.5 (EPT/NON-RI)
23rd Jan 20235:30 pmRNSTP Group
20th Jan 20239:05 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20238:26 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 202312:11 pmRNSForm 8.3 - TP Group plc
18th Jan 202312:09 pmRNSForm 8.3 - TP Group plc
18th Jan 20238:37 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 20238:45 amRNSForm 8.5 (EPT/NON-RI)
16th Jan 202312:53 pmRNSForm 8.3 - TP Group plc
16th Jan 20238:40 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 20239:03 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 20238:46 amRNSForm 8.5 (EPT/NON-RI)
11th Jan 20239:38 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 20239:11 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20238:36 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20237:00 amRNSRegulatory Clearance & Scheme Timetable Update
6th Jan 20238:25 amRNSForm 8.5 (EPT/NON-RI)
5th Jan 20238:17 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 20239:14 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
29th Dec 20223:04 pmRNSSale of Westek Technology Ltd.
29th Dec 20228:44 amRNSForm 8.5 (EPT/NON-RI)
22nd Dec 20228:56 amRNSForm 8.5 (EPT/NON-RI)
21st Dec 202212:22 pmRNSHolding(s) in Company
21st Dec 20229:22 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 202211:10 amRNSForm 8.5 (EPT/NON-RI)
19th Dec 202210:23 amRNSForm 8.5 (EPT/NON-RI)
19th Dec 20229:29 amRNSForm 8.3 - TP Group PLC
15th Dec 20228:58 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 20223:33 pmRNSResult of Court Meeting & General Meeting
14th Dec 202210:26 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20228:34 amRNSForm 8.5 (EPT/NON-RI)
7th Dec 202210:46 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20228:54 amRNSForm 8.5 (EPT/NON-RI)
2nd Dec 202210:02 amRNSForm 8.5 (EPT/NON-RI)
1st Dec 20229:55 amRNSForm 8.5 (EPT/NON-RI)
1st Dec 20228:15 amRNSForm 8.3 -TP Group PLC
30th Nov 20228:54 amRNSForm 8.5 (EPT/NON-RI)
29th Nov 20228:14 amRNSForm 8.3 - TP GROUP PLC
28th Nov 20228:22 amRNSForm 8.3 - TP Group PLC
24th Nov 202210:39 amRNSForm 8.5 (EPT/NON-RI)
24th Nov 20228:28 amRNSForm 8.3 - TP GROUP PLC
23rd Nov 20228:48 amRNSForm 8.3 - TP GROUP PLC
22nd Nov 20229:45 amRNSForm 8.5 (EPT/NON-RI)
22nd Nov 20228:26 amRNSForm 8.3 - TP GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.